COMMUNIQUÉS West-GlobeNewswire

-
Exalenz Announces Second Quarter 2018 Financial Results
31/08/2018 -
Olainfarm’s Six Months Net Profit Reaches 5,78 million euros
31/08/2018 -
Oncology Venture A/S: Publication of financial report for January - June 2018
31/08/2018 -
Cytori Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
31/08/2018 -
Oncology Venture A/S establish a flexible loan facility of up to SEK 40 million
31/08/2018 -
Genmab Announces European Marketing Authorization for DARZALEX® (daratumumab) for Front Line Multiple Myeloma
31/08/2018 -
Zynerba Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference
31/08/2018 -
Portola Pharmaceuticals Submits Prior Approval Supplement to U.S. FDA for Large-Scale Generation 2 Andexxa Process
31/08/2018 -
Selecta Biosciences Announces Presentation at the 20th Asia Pacific League of Associations for Rheumatology Congress (APLAR)
31/08/2018 -
Rubius Therapeutics Reports Second Quarter 2018 Financial Results
31/08/2018 -
Altimmune Announces Initial Single-Dose Data from Its NasoShield Phase 1 Study
31/08/2018 -
Atara Biotherapeutics to Participate at Two Upcoming Conferences
31/08/2018 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2018
31/08/2018 -
Myriad Genetics to Present at the 2018 Morgan Stanley Global Healthcare Conference
31/08/2018 -
Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology
31/08/2018 -
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2018
31/08/2018 -
Cerecor CEO to Present at the H.C. Wainwright Global Investment Conference
31/08/2018 -
Auxly Announces Completion of KGK Science Acquisition
31/08/2018 -
BeiGene Announces Acceptance of New Drug Application for Anti-PD-1 Antibody Tislelizumab in Hodgkin’s Lymphoma in China
31/08/2018
Pages